Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Wall Street Trading Boom Loses Steam; BofA Guides Q3 ‘Flat,’ JPMorgan ‘High Teens’ Growth After Q2 Record-Breaking Equities Run

by Team Lumida
September 18, 2026
in Equities
Reading Time: 4 mins read
A A
0
Wall Street Trading Boom Loses Steam; BofA Guides Q3 ‘Flat,’ JPMorgan ‘High Teens’ Growth After Q2 Record-Breaking Equities Run
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Wall Street executives warned trading revenue growth is slowing sharply in Q3 after unprecedented Q2 performance, signaling boom may be losing steam. Bank of America CEO Brian Moynihan said Q3 sales and trading revenue would be “flat,” causing 5% BofA share drop on announcement. JPMorgan guiding “high teens” percentage growth (vs prior year Q3); Citigroup predicting “mid-single-digit increase” for markets unit; Morgan Stanley co-president noted “3Q is no 2Q.” Goldman Sachs CEO said equities “continues to be very strong” but fixed income/currencies/commodities “a little bit softer.” Goldman shares down 7% past week on guidance concerns.
  • Q2 2025 trading bonanza was exceptional: combined equities trading revenue for JPM, Goldman, Citi, BofA soared 72% year-on-year to $19.3bn, buoyed by rush into AI stocks, Asian semiconductor speculation, and SpaceX’s mega IPO. These trends have started to weaken. BofA noted slowdown in Asia financing; pullback in prime broking (lending to hedge funds, trading firms, family offices) in region. While Goldman said equities remains “very strong,” FICC expected softer. JPMorgan expects “seasonal sequential decline” following record Q2.
  • Slowdown is notable given exceptional Q2 results. Daniel Simkowitz (Morgan Stanley co-president) directly acknowledged: “Second quarter of this year was pretty exceptional in markets…it’s safe to say, 3Q is no 2Q.” This represents significant deceleration from 72% YoY Q2 growth rate across big four banks’ equities trading. Article reflects shift from extraordinary conditions back toward normalized market conditions; AI-linked stock rush, semiconductor volatility, and SpaceX IPO all contributing factors to Q2 spike.
  • Wall Street executives maintain structural optimism despite Q3 slowdown: JPMorgan’s Petno highlighted “much more significant demand” for prime broking and structured financing as structural trends likely to persist. Goldman’s Solomon said growth “not a straight line” but expects long-term US and global market cap to compound, supporting future financing opportunities. Executives signal slowdown is cyclical pullback after Q2 exceptionalism rather than secular demand destruction.

What Happened?

Wall Street bank executives warned Q3 trading revenue growth is slowing significantly after record-breaking Q2. Bank of America CEO Brian Moynihan stated Q3 sales and trading revenue would be “flat” (caused 5% BofA share drop). JPMorgan guiding “high teens” percentage growth vs year-ago Q3; Citigroup predicting mid-single-digit increase for markets unit; Morgan Stanley’s Simkowitz noted Q3 cannot match Q2’s exceptional performance. Goldman Sachs CEO Solomon said equities “very strong” but FICC “softer.” Q2 2025 equities trading revenue for JPM, GS, C, BAC surged 72% year-on-year to $19.3bn, driven by AI stock rush, Asian semiconductor volatility, SpaceX IPO. Asia financing activity slowed; prime broking pullback noted by BofA. Wall Street banks set to report Q3 earnings next month.

Why It Matters?

For bank shareholders, guidance suggests trading revenue decline from Q2 exceptional levels—but not secular deterioration. BofA guidance of “flat” Q3 likely reflects specific Asia headwinds rather than global trading collapse; JPM/GS “high teens” guidance suggests market leadership validated. For institutional investors, slowdown in prime broking and hedge fund lending could signal broader pullback in leverage and risk-taking post-AI stock surge. For markets broadly, trading slowdown could indicate normalization after Q2 spike—suggesting frenzied market activity around AI/SpaceX/semiconductors may have peaked. For investment banking divisions, slowdown is timing issue (Q2 boom benefited from SpaceX IPO; repeat unlikely in Q3).

What’s Next?

Monitor Q3 earnings releases (expected next month) for actual results vs guidance; if trading revenues beat expectations, it would signal guidance was conservative. Watch for prime broking volumes in upcoming quarters; if hedge fund/family office lending rebounds, it would validate JPM’s structural demand thesis. Track Asian financing activity; if BofA’s Asia slowdown eases in Q4, it would suggest regional cyclical weakness rather than structural decline. Monitor equity market volatility (VIX); if volatility rises, it could drive trading revenue higher in Q4 despite Q3 slowdown. Watch CEO commentary on cost-cutting; if banks signal expense reductions to offset lower trading revenues, it could pressure investment banking hiring. Also track CRE lending trends; if commercial real estate credit continues deteriorating, it could pressurize bank balance sheets and capital deployment for trading operations.

Affected Tickers & Coins: BAC, JPM, C, GS, MS

Source: Financial Times

Previous Post

Lucid Partners With Bolt for 25,000 European Robotaxis by 2028; Validates Uber’s $2B Investment as Struggling EV Maker Pursues Profitability

Next Post

Tech Stocks Lead Market Recovery; BOJ Split Vote Weakens Yen 1.3%, Brent Crude Falls Below $104, Anthropic Discloses 25%+ AI R&D Driven by Claude

Recommended For You

NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India

by Team Lumida
2 hours ago
NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India

National Stock Exchange India IPO bids exceed 88.6M shares on offer; institutional and retail portions covered; bidding closes Sept 21 at 1,700-1,785 rupees/share.

Read more

Lucid Partners With Bolt for 25,000 European Robotaxis by 2028; Validates Uber’s $2B Investment as Struggling EV Maker Pursues Profitability

by Team Lumida
2 hours ago
Lucid Partners With Bolt for 25,000 European Robotaxis by 2028; Validates Uber’s $2B Investment as Struggling EV Maker Pursues Profitability

Lucid and Bolt sign MOU for most ambitious European robotaxi rollout; Lucid targets 2028 launch; CEO Napoli calls deal 'important step' for stabilizing finances.

Read more

Mark Walter’s Money: Investigative Probe Into Cash Flows Between Guggenheim Investments and Walter-Controlled Insurers; KPMG Warnings, Prosecutor Scrutiny

by Team Lumida
2 hours ago
Mark Walter’s Money: Investigative Probe Into Cash Flows Between Guggenheim Investments and Walter-Controlled Insurers; KPMG Warnings, Prosecutor Scrutiny

$200M+ in booked revenues at Guggenheim awaiting payment from Walter-controlled entities; KPMG auditor flagged revenue recognition concerns; prosecutors investigating insurance misclassifications.

Read more

Three New ETFs Target Tax Deferral, Next-Generation AI Winners and Hedged Bitcoin Exposure

by Team Lumida
18 hours ago
Three New ETFs Target Tax Deferral, Next-Generation AI Winners and Hedged Bitcoin Exposure

Bloomberg Trillions reviews three recent ETF launches covering tax-deferred structures, an AI index beyond the megacaps, and a hedged bitcoin product.

Read more

Novo Nordisk Partners With Orbis for Oral Biologic Pills Worth $1.4B; Eli Lilly Also Stakeholder in AI Drug Design Startup

by Team Lumida
1 day ago
Novo Nordisk Partners With Orbis for Oral Biologic Pills Worth $1.4B; Eli Lilly Also Stakeholder in AI Drug Design Startup

Novo invests in Orbis to develop oral versions of Ozempic/Wegovy; Orbis uses AI for compound design; Eli Lilly competing as stakeholder.

Read more

Holtec Suspends $900M IPO as ‘Perfect Storm’ Hits AI Data Centre Sector; Nuclear Power Demand Visibility Collapses

by Team Lumida
1 day ago
Rumble Shares Jump as Report Reveals Anthropic as the $13.7 Billion Customer Behind Its August Cloud Deal

Holtec founder Singh cites market sentiment against data centers as reason for IPO withdrawal; nuclear sector aiming to raise billions for AI power infrastructure.

Read more

Reform UK Treasurer Nick Candy Meets Sanctioned Nicaraguan Officials; Metals Exploration Wins 60K-Hectare Mining Rights Days Later

by Team Lumida
1 day ago
Reform UK Treasurer Nick Candy Meets Sanctioned Nicaraguan Officials; Metals Exploration Wins 60K-Hectare Mining Rights Days Later

Metals Exploration awarded 8 concessions adjacent to La India gold mine days after Candy met Laureano Ortega, mining minister, attorney-general; company share price +25% YTD.

Read more

Ion Platform Owner Cuts 20%+ Staff as $11B Debt Burden Buckles Under Rate Hikes and AI Threats to Software Business

by Team Lumida
1 day ago
Ion Platform Owner Cuts 20%+ Staff as $11B Debt Burden Buckles Under Rate Hikes and AI Threats to Software Business

Andrea Pignataro's Mergermarket/Dealogic owner slashing headcount to 4,500 from 6,000; financing costs doubled to $800M/year; bond prices crashed 26% on AI fears.

Read more

DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

by Team Lumida
2 days ago
DOJ Backs $1.9B Bond Requirement for States Challenging Paramount-Warner Bros Merger; Trial Set for March 2027

DOJ urges judge to require states, Writers Guild to post bond; Paramount paying $7M daily fees as deal closure delayed; DOJ-state antitrust enforcement rift widens.

Read more

Walmart Partners With Scan Health Plan to Sell Medicare Advantage Coverage; Costco Also Enters Healthcare Market With Co-Branded Plans

by Team Lumida
2 days ago
Walmart Expands Logistics Services Beyond Its Marketplace: What This Means for Investors

Retailers deploy shopper data and pricing power to enter Medicare Advantage; Walmart and Costco co-brand plans as insurers retreat amid rising medical care costs.

Read more
Next Post
Tech Stocks Lead Market Recovery; BOJ Split Vote Weakens Yen 1.3%, Brent Crude Falls Below $104, Anthropic Discloses 25%+ AI R&D Driven by Claude

Tech Stocks Lead Market Recovery; BOJ Split Vote Weakens Yen 1.3%, Brent Crude Falls Below $104, Anthropic Discloses 25%+ AI R&D Driven by Claude

NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India

NSE IPO Fully Subscribed on Day 2; $2.4B India Offering Values Exchange at 42.9x Earnings, Second-Largest After Hyundai Motor India

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a car is on display in a showroom

Porsche Faces Market Headwinds as China Sales Plunge 28%, Global Deliveries Dip 3%

January 13, 2025
Target Surges Past Sales Slump; Macy’s Struggles to Keep Up

Target Surges Past Sales Slump; Macy’s Struggles to Keep Up

August 21, 2024
Pentagon–Anthropic Feud Escalates as AI Policy Clash Threatens Defense Contracts

Inside the Moment Anthropic Realized Mythos Was Too Dangerous to Release

April 16, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018